{"name":"POLYSAN Scientific & Technological Pharmaceutical Company","slug":"polysan-scientific-technological-pharmaceutical-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":8,"colorKey":"oncology","drugs":[{"name":"Cytoflavin® solution","genericName":"Cytoflavin® solution","slug":"cytoflavin-solution","indication":"Acute ischemic stroke","status":"phase_3"},{"name":"Ringer's Solution","genericName":"Ringer's Solution","slug":"ringer-s-solution","indication":"Fluid resuscitation and volume replacement in hypovolemia","status":"marketed"},{"name":"Runihol","genericName":"Runihol","slug":"runihol","indication":"Other","status":"discontinued"},{"name":"Cycloferon","genericName":"Cycloferon","slug":"cycloferon","indication":"Other","status":"phase_3"},{"name":"Cycloferone","genericName":"Cycloferone","slug":"cycloferone","indication":"Other","status":"phase_2"},{"name":"Placebo enteric-coated tablet","genericName":"Placebo enteric-coated tablet","slug":"placebo-enteric-coated-tablet","indication":"Treatment of symptoms associated with irritable bowel syndrome","status":"phase_3"},{"name":"Reamberin","genericName":"Reamberin","slug":"reamberin","indication":"Other","status":"phase_2"},{"name":"Remaxol","genericName":"Remaxol","slug":"remaxol","indication":"Other","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Cytoflavin® enteric-coated tablet","genericName":"Cytoflavin® enteric-coated tablet","slug":"cytoflavin-enteric-coated-tablet","indication":"Acute ischemic stroke","status":"phase_3"}]}],"pipeline":[{"name":"Cytoflavin® solution","genericName":"Cytoflavin® solution","slug":"cytoflavin-solution","phase":"phase_3","mechanism":"Cytoflavin is a combination drug that enhances cellular energy metabolism and reduces oxidative stress through its active components.","indications":["Acute ischemic stroke","Traumatic brain injury","Hypoxic-ischemic encephalopathy","Acute cerebrovascular disorders"],"catalyst":""},{"name":"Ringer's Solution","genericName":"Ringer's Solution","slug":"ringer-s-solution","phase":"marketed","mechanism":"Ringer's Solution is an intravenous electrolyte replacement fluid that restores fluid balance and electrolyte concentrations in the body.","indications":["Fluid resuscitation and volume replacement in hypovolemia","Maintenance of electrolyte balance in acute care and perioperative settings","Treatment of dehydration"],"catalyst":""},{"name":"Runihol","genericName":"Runihol","slug":"runihol","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cycloferon","genericName":"Cycloferon","slug":"cycloferon","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cycloferone","genericName":"Cycloferone","slug":"cycloferone","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cytoflavin® enteric-coated tablet","genericName":"Cytoflavin® enteric-coated tablet","slug":"cytoflavin-enteric-coated-tablet","phase":"phase_3","mechanism":"Cytoflavin is a combination drug that enhances cellular energy metabolism and reduces oxidative stress through its active components.","indications":["Acute ischemic stroke","Chronic cerebrovascular insufficiency","Metabolic encephalopathy"],"catalyst":""},{"name":"Placebo enteric-coated tablet","genericName":"Placebo enteric-coated tablet","slug":"placebo-enteric-coated-tablet","phase":"phase_3","mechanism":"Small molecule","indications":["Treatment of symptoms associated with irritable bowel syndrome"],"catalyst":""},{"name":"Reamberin","genericName":"Reamberin","slug":"reamberin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Remaxol","genericName":"Remaxol","slug":"remaxol","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOV2g2Q3NJaFNFZmdDa3l2Tlo3cExKWmROemJjOHhzSXdnemhKXzBnSkRaT1FPV1hwcHN1LVZBTnJjTnhIcTlJdmlaOXE2ZHhRUmVFYjhCZW9WelFaSWVNSUdZTzlEa0xDZ1lCR0JJUDZ5WFNwWEhhY0RjOHI0X2VrNHZHdFJuOUtxejYtUDBRLWZNR25rUWw2NmtXazdoRENLV2xN?oc=5","date":"2021-11-25","type":"pipeline","source":"Vietnam+ (VietnamPlus)","summary":"Russian company offers HCM City drugs for COVID-19 treatment - Vietnam+ (VietnamPlus)","headline":"Russian company offers HCM City drugs for COVID-19 treatment - Vietnam+ (VietnamPlus)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNVXRlN0dvRzNMTlhpZ2w3NXIwRjBsa2ZkTFhReVZqdklGYTNDWWVkODNiT0EzT3p5cE55NUVnYVVOOHRSVDN5bm1LU1FuZUlwdERsYXNOYWl5RTFndEhEWmxscHFRY2xSNUlybm5RbW5uLUVGajhyd0tYeVA1WG1aRWZLYVVtQlRVRkQ3cUhkUUdvdnRsbXBFQ0NfWUFYZ093djZKaTc1bzRKbm41ZlEyd2NoUXo5aWM?oc=5","date":"2017-05-31","type":"pipeline","source":"Fierce Pharma","summary":"Plant to produce Pfizer sterile injectables for Russia gets under way - Fierce Pharma","headline":"Plant to produce Pfizer sterile injectables for Russia gets under way","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPaDRIUFl4QVJzUWZaRzhEU1I5RVdZdVdNYkhPcE9YcjFvRFZKYVNqS1hnQjBFNXRHX2ZERjVLSTV6MUJzZjBLWGI3a1phYWJHYWUwbU5iVDZGSGQ4TDJCNmhQQXY5NDVXUjdaQVlQamVkZVdpVGZDWlNMRVRWTHRKLU9GdTBjUkk2R3hucVE1YVJNamNf?oc=5","date":"2016-11-23","type":"deal","source":"Fierce Pharma","summary":"Sun Pharma moves on Russia with deal for control of JSC Biosintez - Fierce Pharma","headline":"Sun Pharma moves on Russia with deal for control of JSC Biosintez","sentiment":"neutral"}],"patents":[],"drugCount":9,"phaseCounts":{"phase_3":5,"marketed":1,"discontinued":1,"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}